Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -1,301 | 118 | 114 | -650 | N/A |
| Accounts receivable | 572 | -1,185 | -124 | 1,194 | 985 |
| Other Working Capital | -8,391 | 7,686 | 1,148 | 2,030 | 1,181 |
| Other Operating Activity | -8,057 | 7,479 | -13,645 | -9,112 | -4,631 |
| Operating Cash Flow | $-17,177 | $14,098 | $-12,507 | $-6,538 | $-2,465 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -109 | 91 | -442 | -362 | -54 |
| Purchase Sale Intangibles | 0 | -121 | N/A | N/A | N/A |
| Investing Cash Flow | $-109 | $-30 | $-442 | $-362 | $-54 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -2,000 | N/A | N/A | N/A |
| Debt Issued | 0 | 25 | N/A | N/A | 0 |
| Debt Repayment | N/A | N/A | -25 | N/A | N/A |
| Common Stock Issued | 0 | 12,364 | 10,000 | 13,447 | 4,383 |
| Other Financing Activity | -49 | -6,409 | -704 | -3 | 0 |
| Financing Cash Flow | $-49 | $3,980 | $9,271 | $13,444 | $4,383 |
| Beginning Cash Position | 23,806 | 5,758 | 9,436 | 2,892 | 1,028 |
| End Cash Position | 6,471 | 23,806 | 5,758 | 9,436 | 2,892 |
| Net Cash Flow | $-17,335 | $18,048 | $-3,678 | $6,544 | $1,864 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,177 | 14,098 | -12,507 | -6,538 | -2,465 |
| Capital Expenditure | -132 | -154 | -444 | -362 | -54 |
| Free Cash Flow | -17,309 | 13,944 | -12,951 | -6,900 | -2,519 |